NATCO PHARMA LTD. - Natco Pharma Ltd reply to clarification sought by the exchange

The Exchange has sought clarification from Natco Pharma Ltd with respect to the disclosure dated December 5, 2014 submitted by Natco Pharma Ltd which inter-alia states "Allotment of Equity Shares on Preferential Basis other than Cash" <BR> <BR>Natco Pharma Ltd was requested to submit its clarification to the Exchange with respect to the following in terms of Clause 36 of the Listing Agreement. <BR><BR>i. Issue period;<BR>ii. Names of the investors and of these, which are promoters or promoter group entities,<BR>iii. Post allotment of securities:- outcome of the subscription, issue price / allotted price (in case of convertibles), number of investors<BR> <BR>Natco Pharma Ltd response is enclosed. Also Company has referred to the AGM notice submitted along with the Annual Report 2014.